Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Treace Medical Concepts, Inc. made materially false and/or misleading statements and/or failed to disclose that: On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on “competitive pressure in its business.” Following this news, Treace’s stock price fell by $6.95 per share, or approximately 62% on the same day.
In order to be eligible to join the TMCI class action lawsuit, you must have incurred a loss on shares of Treace Medical Concepts, Inc. purchased during the class period listed above.
TOP
